Beijing Airdoc Technology Co. Ltd. Class H (HK:2251)
:2251
Want to see HK:2251 full AI Analyst Report?
Top Page
Beijing Airdoc Technology Co. Ltd. Class H
(2251)
Select Model
Select Model
Rating:49Neutral
Price Target:
HK$11.00
▼(-11.58% Downside)
Action:Reiterated
Date:05/16/26
Overall score reflects improving operational trends (re-accelerating revenue growth and stronger gross margin) and a low-debt balance sheet, but is held back by continued losses, negative operating/free cash flow, and weak technical signals with the stock trading below key moving averages.
Positive Factors
Revenue Growth & Unit Economics
Revenue rebound and a jump in gross margin to ~66% reflect improving unit economics and stronger product-market fit for its AI imaging software. Sustained top-line growth with high gross margins supports scalable software economics, enabling reinvestment into sales and R&D to pursue durable, profitable growth over the medium term.
Negative Factors
Persistent Losses
A net margin near -14% means the company remains loss-making despite revenue and margin gains. Ongoing losses erode retained capital and limit the ability to self-fund expansion or cushion downturns. Over multiple quarters this raises the probability of external financing and potential dilution, constraining long-term sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth & Unit Economics
Revenue rebound and a jump in gross margin to ~66% reflect improving unit economics and stronger product-market fit for its AI imaging software. Sustained top-line growth with high gross margins supports scalable software economics, enabling reinvestment into sales and R&D to pursue durable, profitable growth over the medium term.
Read all positive factors
Beijing Airdoc Technology Co. Ltd. Class H (2251) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.06B
Dividend YieldN/A
Average Volume (3M)61.23K
Price to Earnings (P/E)―
Beta (1Y)0.71
Revenue Growth10.88%
EPS Growth90.15%
CountryHK
Employees248
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.24
Shares Outstanding103,568,016
10 Day Avg. Volume99,440
30 Day Avg. Volume61,230
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)0.85
Price to Sales (P/S)6.06
P/FCF Ratio-49.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.37
Revenue Forecast (FY)HK$251.57M
Beijing Airdoc Technology Co. Ltd. Class H Business Overview & Revenue Model
Company Description
Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions for medical institutions and consumer healthcare providers in Mainland China and internationally. It offers Air...
How the Company Makes Money
The company primarily makes money by selling access to, licensing, and/or deploying its AI medical imaging software and related solutions to healthcare customers (e.g., hospitals, clinics, and screening providers), where revenue is typically gener...
Beijing Airdoc Technology Co. Ltd. Class H Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
82
Very Positive
Cash Flow
38
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 173.26M | 156.37M | 203.96M | 113.66M | 115.18M |
| Gross Profit | 127.33M | 86.68M | 125.13M | 55.85M | 70.24M |
| EBITDA | -8.00M | -259.70M | -113.36M | -159.64M | -126.73M |
| Net Income | -24.98M | -255.46M | -132.53M | -180.00M | -142.63M |
Balance Sheet | |||||
| Total Assets | 1.31B | 1.41B | 1.68B | 1.74B | 1.89B |
| Cash, Cash Equivalents and Short-Term Investments | 650.73M | 774.82M | 1.14B | 1.41B | 1.78B |
| Total Debt | 26.93M | 31.88M | 9.37M | 8.01M | 8.20M |
| Total Liabilities | 88.07M | 134.86M | 127.13M | 68.59M | 74.19M |
| Stockholders Equity | 1.23B | 1.27B | 1.54B | 1.67B | 1.82B |
Cash Flow | |||||
| Free Cash Flow | -21.09M | -167.51M | 8.02M | -392.55M | -140.11M |
| Operating Cash Flow | -20.03M | -165.43M | 23.37M | -380.44M | -112.09M |
| Investing Cash Flow | -49.99M | -11.34M | -385.14M | -154.43M | -22.01M |
| Financing Cash Flow | -26.55M | -33.31M | -18.53M | -17.14M | 1.55B |
Beijing Airdoc Technology Co. Ltd. Class H Technical Analysis
Negative
12.44
Price Trends
11.51
Negative
11.76
Negative
12.46
Negative
Market Momentum
-0.13
Positive
41.58
Neutral
33.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2251, the sentiment is Negative. The current price of 12.44 is above the 20-day moving average (MA) of 11.62, above the 50-day MA of 11.51, and below the 200-day MA of 12.46, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 41.58 is Neutral, neither overbought nor oversold. The STOCH value of 33.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2251.
Beijing Airdoc Technology Co. Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$1.84B | 9.50 | 7.66% | 9.29% | -3.21% | -6.77% | |
64 Neutral | HK$1.39B | 20.66 | 5.64% | 1.20% | 1.75% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$1.06B | -42.03 | -1.97% | ― | 10.88% | 90.15% | |
48 Neutral | HK$490.79M | 178.27 | -34.57% | 2.15% | -15.53% | ― | |
45 Neutral | HK$5.72B | -109.53 | -2.28% | ― | -4.99% | 47.18% | |
44 Neutral | HK$1.82B | -7.60 | -27.70% | ― | -100.00% | 50.29% |
* Healthcare Sector Average
HK:2251
Beijing Airdoc Technology Co. Ltd. Class H
10.43
-1.97
-15.89%
HK:2158
Yidu Tech, Inc.
5.30
-0.43
-7.50%
HK:2219
Chaoju Eye Care Holdings Ltd.
2.66
0.31
13.29%
HK:2325
Yunkang Group Limited
0.75
-3.11
-80.57%
HK:3309
C-MER Eye Care Holdings Limited
1.11
-0.57
-33.93%
HK:3681
SinoMab Bioscience Ltd.
1.30
0.04
3.17%
Beijing Airdoc Technology Co. Ltd. Class H Corporate Events
Beijing Airdoc Narrows Losses on Higher 2025 Revenue and Improved Margins
Mar 31, 2026
Beijing Airdoc Technology reported revenue of RMB173.3 million for 2025, up from RMB156.4 million a year earlier, driven by growth in its AI-enabled healthcare solutions. The company operates with substantial non-current assets and a solid equity ...
Beijing Airdoc Sets March 31 Board Meeting to Approve 2025 Results
Mar 19, 2026
Beijing Airdoc Technology Co., Ltd. has scheduled a board meeting for March 31, 2026 to review and approve the annual results for the year ended December 31, 2025, along with their release to the market. The board will also consider recommending a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.